Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada: a test-negative design study
Hannah Chung, Siyi He, View ORCID ProfileSharifa Nasreen, Maria E. Sundaram, Sarah A. Buchan, Sarah E. Wilson, Branson Chen, Andrew Calzavara, Deshayne B. Fell, Peter C. Austin, Kumanan Wilson, Kevin L. Schwartz, Kevin A. Brown, Jonathan B. Gubbay, Nicole E. Basta, Salaheddin M. Mahmud, Christiaan H. Righolt, View ORCID ProfileLawrence W. Svenson, View ORCID ProfileShannon E. MacDonald, Naveed Z. Janjua, Mina Tadrous, Jeffrey C. Kwong on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators
doi: https://doi.org/10.1101/2021.05.24.21257744
Hannah Chung
1ICES, Toronto, ON
MPHSiyi He
1ICES, Toronto, ON
MScSharifa Nasreen
1ICES, Toronto, ON
PhDMaria E. Sundaram
1ICES, Toronto, ON
2Dalla Lana School of Public Health, University of Toronto, Toronto, ON
PhDSarah A. Buchan
1ICES, Toronto, ON
2Dalla Lana School of Public Health, University of Toronto, Toronto, ON
3Public Health Ontario, ON
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON
PhDSarah E. Wilson
1ICES, Toronto, ON
2Dalla Lana School of Public Health, University of Toronto, Toronto, ON
3Public Health Ontario, ON
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON
MD MScBranson Chen
1ICES, Toronto, ON
MScAndrew Calzavara
1ICES, Toronto, ON
MScDeshayne B. Fell
1ICES, Toronto, ON
5School of Epidemiology and Public Health, University of Ottawa, ON
6Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON
PhDPeter C. Austin
1ICES, Toronto, ON
7Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON
PhDKumanan Wilson
8Department of Medicine, University of Ottawa, Ottawa and Bruyere Hospital Research Institutes, Ottawa, ON
MD MScKevin L. Schwartz
1ICES, Toronto, ON
2Dalla Lana School of Public Health, University of Toronto, Toronto, ON
3Public Health Ontario, ON
MD MScKevin A. Brown
1ICES, Toronto, ON
2Dalla Lana School of Public Health, University of Toronto, Toronto, ON
3Public Health Ontario, ON
PhDJonathan B. Gubbay
3Public Health Ontario, ON
MD MScNicole E. Basta
9Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC
PhDSalaheddin M. Mahmud
10Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, University of Manitoba, Winnipeg, MB
MD PhDChristiaan H. Righolt
10Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, University of Manitoba, Winnipeg, MB
PhDLawrence W. Svenson
11Analytics and Performance Reporting Branch, Alberta Health, Edmonton, AB
12Division of Preventive Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB
13School of Public Health, University of Alberta, Edmonton, AB
14Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB
PhDShannon E. MacDonald
13School of Public Health, University of Alberta, Edmonton, AB
15Faculty of Nursing, University of Alberta, Edmonton, AB
PhDNaveed Z. Janjua
16British Columbia Centre for Disease Control, Vancouver, BC
17School of Population and Public Health, University of British Columbia, Vancouver, BC
DrPHMina Tadrous
1ICES, Toronto, ON
18Women’s College Hospital, Toronto, ON
PharmD PhDJeffrey C. Kwong
1ICES, Toronto, ON
2Dalla Lana School of Public Health, University of Toronto, Toronto, ON
3Public Health Ontario, ON
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON
19Department of Family and Community Medicine, University of Toronto, Toronto, ON
20University Health Network, Toronto, ON
MD MScArticle usage
Posted July 26, 2021.
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada: a test-negative design study
Hannah Chung, Siyi He, Sharifa Nasreen, Maria E. Sundaram, Sarah A. Buchan, Sarah E. Wilson, Branson Chen, Andrew Calzavara, Deshayne B. Fell, Peter C. Austin, Kumanan Wilson, Kevin L. Schwartz, Kevin A. Brown, Jonathan B. Gubbay, Nicole E. Basta, Salaheddin M. Mahmud, Christiaan H. Righolt, Lawrence W. Svenson, Shannon E. MacDonald, Naveed Z. Janjua, Mina Tadrous, Jeffrey C. Kwong
medRxiv 2021.05.24.21257744; doi: https://doi.org/10.1101/2021.05.24.21257744
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada: a test-negative design study
Hannah Chung, Siyi He, Sharifa Nasreen, Maria E. Sundaram, Sarah A. Buchan, Sarah E. Wilson, Branson Chen, Andrew Calzavara, Deshayne B. Fell, Peter C. Austin, Kumanan Wilson, Kevin L. Schwartz, Kevin A. Brown, Jonathan B. Gubbay, Nicole E. Basta, Salaheddin M. Mahmud, Christiaan H. Righolt, Lawrence W. Svenson, Shannon E. MacDonald, Naveed Z. Janjua, Mina Tadrous, Jeffrey C. Kwong
medRxiv 2021.05.24.21257744; doi: https://doi.org/10.1101/2021.05.24.21257744
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)